Recent studies on instances of Brugada syndrome arrhythmias treated with Implantable Cardioverter Defibrillator (ICD) therapy have determined that the ICDs are effective in quelling potentially fatal arrhythmias in patients. Brugada syndrome is a genetic disorder causing arrhythmias in otherwise normal patients and is the major cause of sudden unexplained death syndrome in adults. Brugada syndrome is commonly diagnosed with an abnormal electrocardiogram (ECG).
An ICD detects abnormal heart rhythms, then treats those abnormalities with a stimulus in the form of an electrical shock delivered to the heart via wires connecting the ICD to the heart muscle. For patients with Brugada syndrome, ICDs have been found to treat potentially lethal arrhythmias. 17% of at-risk, asymptomatic patients predisposed to life-threatening ventricular arrhythmias survived otherwise fatal ventricular episodes because of ICD therapy. “On the basis of our findings, risk stratification by means of